Brief: Schott Pharma Maintains Full-Year Guidance For 2025

SCHOTT Pharma AG & Co KgaA

10/04/2025 17:19

April 10 (Reuters) - SCHOTT PHARMA AG & CO KGAA 1SXP.DE:

PRELIMINARY Q2 2025 FIGURES EXCEED CAPITAL MARKET EXPECTATIONS

MAINTAINS FULL-YEAR GUIDANCE FOR 2025

EXPECTS Q2 2025 EBITDA OF EUR 72M

EXPECTS Q2 2025 REVENUES OF EUR 252M

Source text: ID:nEQ2QTpNza

Further company coverage: 1SXP.DE

 (Gdansk Newsroom)

 (((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))